Subscribe now

Health

Ozempic and Wegovy linked to a lower risk of cannabis use disorder

An analysis of almost 700,000 people with type 2 diabetes or obesity found that those prescribed Ozempic or Wegovy were about half as likely to develop cannabis use disorder as those taking other medications

By Grace Wade

21 March 2024

Pen injection of ozempic

Ozempic is often used to treat type 2 diabetes, but it might also lower the risk of cannabis use disorder

fcm82/Shutterstock

People prescribed Ozempic or Wegovy are less likely to develop a cannabis use disorder or relapse from the condition than those who take other diabetes or obesity medications, suggesting that the popular injections may treat cannabis addiction.

Ozempic and Wegovy are brand names for semaglutide, a drug that reduces appetite and regulates blood sugar levels. It is now routinely prescribed to treat type 2 diabetes and obesity, and some…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

View introductory offers

No commitment, cancel anytime*

Offer ends 2nd of July 2024.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account